Finance

Lists
GANX:NASDAQ
Gain Therapeutics Inc
US$ १.७५
-३.८५%
(-०.०७०) 1D
US$ १.७५
०.००% (०.००)
After hours
Closed: जुलाई २४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
US$ १.८१
High
US$ १.८१
Low
US$ १.७४
Mkt. cap
७.४६ करोड
Avg. vol.
११.३४ लाख
Volume
४.७२ लाख
52-wk high
US$ ४.३४
52-wk low
US$ १.४१
EPS
-US$ ०.६०
Beta
०.१५
Shares outstanding
४.२७ करोड
No. of employees
२१
Open
US$ १.८१
High
US$ १.८१
Low
US$ १.७४
Mkt. cap
७.४६ करोड
Avg. vol.
११.३४ लाख
Volume
४.७२ लाख
52-wk high
US$ ४.३४
52-wk low
US$ १.४१
EPS
-US$ ०.६०
Beta
०.१५
Shares outstanding
४.२७ करोड
No. of employees
२१
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
५४ मिनेट पहिले
USA Rare Earth (USAR) Acquires 13.6% Of Carester To Deepen Its European Footprint
Seeking Alpha
Seeking Alpha
·
२५ मिनेट पहिले
S&P 500 Snapshot: Index Ends Choppy Week In The Red
The Frederick News-Post
The Frederick News-Post
·
१ घण्टा पहिले
Stocks waver on Wall Street while crude oil prices fall for the first time in a week
Fox Business
Fox Business
·
१४ घण्टा पहिले
Nasdaq slides: Magnificent Seven wipes out $797 billion in market value
About Gain Therapeutics Inc
CEO-
Employees२१
Founded२०१७
Headquarters-
Sector-
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current US$ १.७५
US$ ८.०० (+३५७.१४%)
Average
US$ ७.२० (+३११.४३%)
Lowest
US$ ५.०० (+१८५.७१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ७.००
+३००%
07/01/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$ ८.००
+३५७.१%
07/01/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ८.००
+३५७.१%
07/01/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ ५.००
+१८५.७%
05/26/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
US$ ८.००
+३५७.१%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
-
-
-
-
Cost of goods sold
२७.२२ लाख
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
Cost of revenue
२७.२२ लाख
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.७२ लाख
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
Operating expense
२३.७२ लाख
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
Total operating expenses
५०.९५ लाख
४७.९१ लाख
४४.७१ लाख
५३.५४ लाख
Operating income
-५०.९५ लाख
-४७.९१ लाख
-४४.७१ लाख
-५३.५४ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-५६.६८ लाख
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
EBT excluding unusual items
-५६.६८ लाख
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
Income tax expense
१.४१ लाख
५.४९ लाख
७०.१२ हजार
१.८३ लाख
Effective tax rate
-२.४९%
-११.६०%
-१.५७%
-३.३७%
Other operating expenses
-
-
-
-
Net income
-५८.०९ लाख
-५२.८४ लाख
-४५.३८ लाख
-५६.०९ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१९
-०.१५
-०.११
-०.१३
Interest and investment income
४७.६४ हजार
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
Interest expense
-
-
-
-
Net interest expenses
४७.६४ हजार
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-५०.८५ लाख
-४७.८० लाख
-४४.५६ लाख
-५३.४५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer